Bayer Cropscience Declares Rs. 90 Interim Dividend Amid Mixed Q2 Results
Bayer Cropscience announced an interim dividend of Rs. 90 per share, totaling Rs. 4,045 million, payable on December 3, 2025. Q2 FY2025-26 results show a 10.6% decline in revenue to Rs. 15,534 million, but improved profitability with EBITDA up 13.9% to Rs. 2,050 million and net profit increasing 12.5% to Rs. 1,530 million. The EBITDA margin expanded by 264 basis points to 13.22%. The company operates in the 'Agri Care' segment and reported total assets of Rs. 51,910 million as of September 30, 2025.

*this image is generated using AI for illustrative purposes only.
Bayer Crop Science , a key player in the agrochemical sector, has announced a substantial interim dividend while reporting mixed financial results for the second quarter.
Dividend Announcement
The Board of Directors of Bayer Cropscience has declared an interim dividend of Rs. 90 per equity share. This dividend, amounting to Rs. 4,045 million, will be paid to shareholders whose names appear in the company's Register of Members as of November 14, 2025, which is set as the record date. The payment is scheduled for December 3, 2025.
Financial Performance
The company's financial results for Q2 present a mixed picture:
| Metric | Q2 FY2025-26 | Q2 FY2024-25 | Change |
|---|---|---|---|
| Revenue from Operations | Rs. 15,534 million | Rs. 17,382 million | -10.6% |
| EBITDA | Rs. 2,050 million | Rs. 1,800 million | +13.9% |
| EBITDA Margin | 13.22% | 10.58% | +264 bps |
| Net Profit | Rs. 1,530 million | Rs. 1,360 million | +12.5% |
Despite a 10.6% year-over-year decline in revenue from operations, Bayer Cropscience managed to improve its profitability. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased by 13.9% to Rs. 2,050 million, with the EBITDA margin expanding by 264 basis points to 13.22%. Net profit also saw a healthy increase of 12.5%, reaching Rs. 1,530 million.
Segment Performance
Bayer Cropscience operates in a single reportable business segment, "Agri Care." The company notes that its business is seasonal in nature, cautioning that quarterly figures may not be representative of full-year performance.
Balance Sheet Highlights
As of September 30, 2025, Bayer Cropscience reported:
- Total Assets: Rs. 51,910 million
- Total Equity: Rs. 31,235 million
- Cash and Cash Equivalents: Rs. 6,579 million
Auditor's Review
The financial results have been subjected to a limited review by the company's statutory auditors, Deloitte Haskins & Sells LLP. The auditors have not reported any material misstatements in the financial results.
Conclusion
While Bayer Cropscience faces challenges in revenue growth, the company has demonstrated resilience by improving its profitability metrics. The substantial interim dividend of Rs. 90 per share signals confidence in the company's financial position and commitment to shareholder returns. However, investors should consider the seasonal nature of the business and potential market volatilities in the agrochemical sector when evaluating the company's performance.
Historical Stock Returns for Bayer Crop Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.88% | +2.50% | -5.88% | -18.50% | -17.56% | -7.38% |
































